Akèy › Twoub depresif majè › Texas › Houston
Etid klinik pou Twoub depresif majè nan Houston, TX
16 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Ap rekriteFaz 3
- Baylor College of Medicine, Houston
- Houston Clinical Trials LLC, Bellaire · 7 mi lwen
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Ap rekriteFaz 3
- DM Clinical Research, Houston
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Ap rekriteFaz 3
- John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Ap rekriteFaz 3
- Brain Health Consultants and TMS Center, Houston
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Ap rekriteFaz 3
- Vanda Investigational Site, Houston
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Ap rekriteFaz 1Volontè an sante akeyi
- Wells Medicine, Houston
- Texas A&M (Houston Methodist Hospital Location), Houston
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Ap rekriteFaz 2
- Baylor College of Medicine, Houston
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Ap rekrite
- CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
- The Methodist Hospital, Houston
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Ap rekriteFaz 2
- Elevate Synapsis, LLC, Atascocita · 20 mi lwen
- Synapsis Bio, Atascocita · 20 mi lwen
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Bellaire · 7 mi lwen
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Houston
- Neurocrine Clinical Site, Bellaire · 7 mi lwen
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Ap rekriteFaz 3
- Clinical Research Site, Houston
- Clinical Research Site, Bellaire · 7 mi lwen
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Ap rekriteFaz 2
- Houston Clinical Trials - Bellaire /ID# 277551, Bellaire · 7 mi lwen
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
Ap rekrite
- Houston Center For Advanced Psychiatric Treatment, Houston
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Houston
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
Ap rekriteVolontè an sante akeyi
- Michael E. DeBakey VA Medical Center, Houston
- The University of Texas health Science Center at Houston, Houston
Etid Twoub depresif majè nan lòt vil
- New York City, NY37 etid
- Boston, MA31 etid
- Atlanta, GA25 etid
- Philadelphia, PA23 etid
- Orlando, FL19 etid
- Miami, FL18 etid
- Tampa, FL17 etid
- Chicago, IL17 etid
- San Diego, CA16 etid
- Little Rock, AR14 etid
- Orange, CA13 etid
- Austin, TX13 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.